CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 20, 2024 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 42,379 | $14.26 | 201,692 |
| Feb 20, 2024 |
Director, President & CEO
Trans History: 126
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 185,100 | -- | 988,804 |
| Feb 20, 2024 |
Director, President & CEO
Trans History: 126
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 118,017 | $14.26 | 870,787 |
| Feb 20, 2024 |
Chief Innovation Officer
Trans History: 50
|
Chief Innovation Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 59,377 | -- | 305,605 |
| Feb 20, 2024 |
Chief Innovation Officer
Trans History: 50
|
Chief Innovation Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 41,872 | $14.26 | 263,733 |
| Feb 20, 2024 |
Chief Operating Officer
Trans History: 24
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 59,377 | -- | 274,993 |
| Feb 20, 2024 |
Chief Operating Officer
Trans History: 24
|
Chief Operating Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 41,489 | $14.26 | 233,504 |
| Feb 16, 2024 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 96,328 |
| Feb 16, 2024 |
Director
Trans History: 26
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 161,908 |
| Feb 16, 2024 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 80,671 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.